Annovis Bio Inc. (ANVS)
NYSE: ANVS
· Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT
Annovis Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.24B | -29.06M | -24.59M | -40.94M | -34.73M | -39.25M | -47.92M | -28.8M | -29.99M | -29.17M | -25.33M | -28.15M | -23.38M | -17.18M | -14.49M | -10.28M | -8.44M | -8.22M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 129K | 129K | 129K |
Stock-Based Compensation | 498.99M | 3.97M | 3.84M | 3.24M | 3.48M | 3.45M | 4.63M | 5.2M | 6.93M | 7.26M | 9.15M | 11.57M | 10M | 8.11M | 4.7M | 942.53K | 785.61K | 1.89M |
Other Working Capital | -6.82M | -3.29M | -4.17M | -2.04M | 5.8M | 3.62M | 2.44M | -2.41M | -6.04M | -7.23M | -4.41M | -454.82K | -650.28K | -710.43K | 311.13K | 1.06M | 356.21K | 85.92K |
Other Non-Cash Items | 628.48M | 8.16M | 2.02M | 14.6M | -2.97M | 4.34M | 12.39M | -102.47K | 6.66M | 4.04M | 5.88M | 10.02M | 9.21M | 8M | 4.35M | -372.98M | -373.58M | -374.3M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 373.72M | 373.72M | 373.72M |
Change in Working Capital | -8.85M | -6.03M | -3.16M | 128.83K | 8.03M | 3.57M | -228.6K | -2.33M | -5.77M | -4.01M | -1.14M | 1.1M | 141.73K | -606K | 657.35K | 1.21M | 341.59K | 855.95K |
Operating Cash Flow | -5.13B | -22.96M | -21.89M | -22.97M | -26.2M | -32.44M | -37.03M | -31.27M | -28.83M | -25.92M | -17.31M | -15.47M | -13.23M | -9.68M | -9.13M | -8.13M | -7.31M | -5.48M |
Capital Expenditures | 0.00 | 5.00 | 1.00 | 1.00 | 1.00 | -4 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.46 | -25.46 | -25.46 | -25.46 | n/a | -45.39K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.48M | 7.48M | 8.02M | 8.47M | 990K | 991K | 458.38K | 4.62M | 4.62M | 4.62M | 4.61M | 95.01M | 95.01M | 95.1M | 95.1M | 9.3M | 9.3M | 9.27M |
Financial Cash Flow | 37.82M | 42.06M | 26.69M | 29.26M | 17.42M | 21.75M | 17.34M | 13.19M | 13.19M | 4.62M | 4.61M | 46.7B | 46.7B | 46.74B | 46.74B | 12.08B | 12.08B | 12.03B |
Net Cash Flow | 6.58B | 11.69B | 4.8M | 6.28M | -24.51M | -26.41M | -35.41M | -38.42M | -20.25M | -25.91M | -17.31M | -15.47M | -13.25M | 37.07M | 37.61M | 38.61M | 39.46M | -5.52M |
Free Cash Flow | -13.22B | -8.11B | -21.89M | -22.97M | -26.2M | -32.44M | -37.03M | -31.27M | -28.83M | -25.92M | -17.31M | -15.47M | -13.23M | -9.68M | -9.13M | -8.13M | -7.31M | -5.48M |